CVS Caremark president David Joyner (Carolyn Kaster/AP Images)
September 11, 2024 03:09 PM EDTUpdated September 12, 06:18 AM
Law

CVS says it won't cor­rect con­gres­sion­al tes­ti­mo­ny

Drew Armstrong

Executive Editor

The head of CVS Health’s PBM unit won’t cor­rect tes­ti­mo­ny giv­en to Con­gress, the com­pa­ny’s lawyers said in a let­ter to the House Over­sight Com­mit­tee …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times